Clinical efficacy of the fourth dose of the BNT162b2 vaccine in maintenance dialysis patients.

Cohen-Hagai, Keren; Hornik-Lurie, Tzipi; Benchetrit, Sydney; Nacasch, Naomi; Grupper, Ayelet; Einbinder, Yael; Wand, Ori; Shashar, Moshe

Cohen-Hagai, Keren; Hornik-Lurie, Tzipi; Benchetrit, Sydney; Nacasch, Naomi; Grupper, Ayelet; Einbinder, Yael; Wand, Ori; Shashar, Moshe.

Afiliação

Cohen-Hagai K; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Hornik-Lurie T; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Benchetrit S; Data Research Department, Meir Medical Center, Kfar Saba, Israel.
Nacasch N; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Grupper A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Einbinder Y; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Wand O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shashar M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

J Nephrol ; 36(7): 1957-1964, 2023 09.

Article em En | MEDLINE | ID: mdl-37326951

Assuntos

COVID-19; Idoso; Idoso de 80 Anos ou mais; Humanos; Pessoa de Meia-Idade; Vacina BNT162; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacinas contra COVID-19/efeitos adversos; Diálise Renal/efeitos adversos; Estudos Retrospectivos; SARS-CoV-2; Resultado do Tratamento; Vacinas

Palavras-chave

All-cause mortality; Breakthrough SARS-CoV-2 infections; COVID-19; COVID-19related mortality; Kidney dialysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: J Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google